CD4 and chronic lung disease: Secondary PjP prophylaxis can therefore be safely discontinued in asymptomatic patients on ART with plasma viral loads of <400 copies/mL, a CD4 count above 100 cells/μL, and no other risk factors for PjP, such as additional immunosuppression or chronic lung disease.